Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats

Physiological Research

Volumn 55, Issue 4, 2006, Pages 373-379

  Kadlecova M ^a   Hojna S ^a   Bohuslavova, R ^b   Hubacek J A ^b   Zicha, J ^a   Kunes J ^a  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Apolipoprotein A5; Chronic fructose loading; Gene expression; Genetic analysis; Hypertriglyceridemia; Metabolic syndrome; Rat

Indexed keywords

APOLIPOPROTEIN A5; FRUCTOSE; GENOMIC DNA; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; GENE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC VARIABILITY; HYPERTRIGLYCERIDEMIA; ISCHEMIC HEART DISEASE; METABOLIC SYNDROME X; NONHUMAN; RAT; SEQUENCE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS; BASE SEQUENCE; BODY WEIGHT; FRUCTOSE; HYPERTRIGLYCERIDEMIA; INTRONS; MALE; METABOLIC SYNDROME X; MOLECULAR SEQUENCE DATA; RATS; RATS, INBRED LEW; RATS, MUTANT STRAINS; RATS, WISTAR; TRIGLYCERIDES;

EID: 33747872926     PISSN: 08628408     EISSN: 08628408     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. ABERLE J, EVANS D, BEIL FU, SEEDORF U: A polymorphism in the apolipoprotein A5 is associated with weight loss after short-term diet. Clin Genet 68: 152-154, 2005.
2. BRUNS GA, KARATHANASIS SK, BRESLOW JL: Human apolipoprotein A-I-C-III gene complex is located on chromosome 11. Arteriosclerosis 4: 97-102, 1984.
3. ENDO K, YANAGI H, ARAKI J, HIRANO C, YAMAKAWA-KOBAYASHI K, TOMURA S: Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 111: 570-572, 2002.
4. EVANS D, BUCHWALD A, BEIL FU: The single nucleotide polymorphism -1131T>C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 81: 645-654, 2003.
5. FRUCHART-NAJIB J BAUGE E, NICULESCU LS, PHAM T, THOMAS B, ROMMENS C, MAJD Z, BREWER B, PENNACCHIO LA, FRUCHART JC: Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 319: 397-404, 2004.
6. GENEST J. JR., MCNAMARA JR, ORDOVAS JM, JENNER JL, SILBERMAN SR, ANDERSON KM, WILSON PW, SALEM DN, SCHAEFER EJ: Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 19: 792-802, 1992.
7. GROENENDIJK M, CANTOR EM, DE BRUIN TW, DALLINGA-THIE GM: The apoAI-CIII-AIV gene cluster. Atherosclerosis 157: 1-11, 2001.
8. HOŘÍNEK A, VRÁBLÍK M, ČEŠKA R, ADÁMKOVÁ V, POLEDNE R, HUBÁČEK JA: T-1131→C polymorphism within the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167: 369-370, 2003.
9. HUBÁČEK JA: Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med 43: 897-902, 2005.
10. HUBÁČEK JA, ADÁMKOVÁ V, ČESKA R, POLEDNE R, HOŘÍNEK A, VRÁBLÍK M. New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res 53: 225-228, 2004a.
11. HUBÁČEK JA, ŠKODOVÁ Z, ADÁMKOVÁ V, LÁNSKÁ V, POLEDNE R: The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 65: 126-130, 2004b.
12. HUBÁČEK JA, ŠKODOVÁ Z, LÁNSKÁ V, STÁVEK P, ADÁMKOVÁ V, POLEDNE R: Apolipoprotein AV variants do not affect C-reactive protein levels in Caucasian males. Physiol Res 54: 687-689, 2005.
13. JANG Y, KIM JY, KIM OY, LEE JE, CHO H, ORDOVAS JM, LEE JH: The -1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 80: 832-840, 2004.
14. JEPPESEN J, HEIN HO, SUADICANI P, GYNTELBERG F: Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97: 1029-1036, 1998.
15. KARATHANASIS SK: Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII and AIV genes. Proc Natl Acad Sci USA 82: 6374-6378, 1985.
16. KUNEŠ J, DOBEŠOVÁ Z, ZICHA J: High blood pressure of hypertriglyceridaemic rats is related to metabolic disturbances. Physiol Res 44: 421-424, 1995.
17. MAJESKY MW: Mouse model for atherosclerotic plaque rupture. Circulation 105: 2010-2011, 2002.
18. NABIKA T, NASREEN S, KOBAVASHI S, MASUDA J: The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 165: 201-204, 2002.
19. PENNACCHIO LA, RUBIN EM: Apolipoprotein A5, a newly identified gene that affects plasma triglyceride levels in humans and mice. Arterioscler Tromb Vasc Biol 23: 529-534, 2003.
20. PENNACCHIO LA, OLIVIER M, HUBÁČEK JA, COHEN JC, COX DR, FRUCHART JC, KRAUSS RM, RUBIN EM: An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294: 169-173, 2001.
21. PENNACCHIO LA, OLIVIER M, HUBÁČEK JA, KRAUSS RM, RUBIN EM, COHEN JC: Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11: 3031-3038, 2002.
22. RIBALTA J, FIGUERA L, FERNANDEZ-BALLART J, VILELLA E, CASTRO CABEZAS M, MASANA L, JOVEN J: Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 48: 1597-1600, 2002.
23. SCHAAP, FG, RENSEN PC, VOSHOL PJ, VRINS C, VAN DER VLIET HN, CHAMULEAU RA, HAVEKES LM, GROEN AK, VAN DIJK KW: ApoAV reduces plasma triglycerides by inhibiting very low density lipoproteintriglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 279: 27941-27947, 2004.
24. ŠEDA O, ŠEDOVÁ L: New apolipoprotein A-V: comparative genomics meets metabolism. Physiol Res 52: 141-146, 2003.
25. ŠTOLBA P, DOBEŠOVÁ Z, HUŠEK P, OPLTOVÁ H, ZICHA J, VRÁNA A, KUNEŠ J: The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51: 733-740, 1992.
26. TALMUD PJ, HAWE E, MARTIN S, OLIVIER M, MILLER GJ, RUBIN EM, PENNACCHIO LA, HUMPHRIES SE: Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11: 3039-3046, 2002.
27. UENO T, TREMBLAY J, KUNEŠ J, ZICHA J, DOBEŠOVÁ Z, PAUSOVÁ Z, DENG AY, SUN YL, JACOB HJ, HAMET P: Rat model of familial combined hyperlipidemia as a result of comparative mapping. Physiol Genomics 17: 38-47, 2004.
28. VRÁBLÍK M, HOŘÍNEK A, ČEŠKA R, ADÁMKOVÁ V, POLEDNE R, HUBÁČEK JA: Ser 19→Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people. J Med Genet 40: e105, 2003.
29. VRÁNA A, KAZDOVÁ L: The hereditary hypertriglyceridemic nonobese rat: an experimental model of human hypertriglyceridemia. Transplant Proc 22: 2579, 1990.